Medtronic announces voluntary recall of Diabetes Infusion Sets MiniMed worldwide Ruby Khatun Khatun14 Sept 2017 5:07 AMDUBLIN: Medtronic plc announced that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all...
Lupin to add GLP 1 analog to its diabetes portfolio in India Ruby Khatun Khatun13 Sept 2017 9:37 AMMumbai: Lupin plans to introduce a new class of diabetes drugs in India through in-licensing agreements in order to enhance its diabetes drugs...
Biocon up 5 per cent as Malaysia arm gets GMP compliance certificate Ruby Khatun Khatun10 Sept 2017 5:49 AMNew Delhi: Shares of biopharmaceutical firm Biocon surged over 5 per cent after the company said its Malaysian arm Biocon Sdn Bhd has received EU GMP...
Novo Nordisk settles US probe over diabetes drug for nearly 58.7 million dollar Ruby Khatun Khatun7 Sept 2017 5:18 AMNovo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of U.S. Food and Drug...
Biocon gets JDRF support for global study on diabetes molecule Ruby Khatun Khatun7 Sept 2017 4:32 AMNew Delhi: Biotechnology major Biocon on Thursday said it has received financial support from the US-based JDRF for a global clinical study of its...
Roche wants to expand diabetes business, not sell it supriya kashyap kashyap2 Feb 2017 5:57 AMRoche is looking to expand its $2 billion-per-year diabetes business, not sell it or spin it off.Diagnostics division head Roland Diggelmann dismissed...
FDA approves Medtronics MiniMed 670G-automated insulin delivery device for type 1 diabetes savita thakur thakur29 Sept 2016 7:17 AMThe U.S. Food and Drug Administration approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA approved device that is intended to...
